Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients (Q42276769)

19 October 2017

Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients (English)

1 reference

19 October 2017

Pseudomonas aeruginosa

0 references

1 reference

1 reference

9

1 reference

19 October 2017

Enrico Maria Trecarichi

object named as

Enrico Maria Trecarichi

3

0 references

Mariano Alberto Pennisi

object named as

Mariano Alberto Pennisi

7

0 references

Mario Tumbarello

1

object named as

Mario Tumbarello

1 reference

19 October 2017

Gennaro De Pascale

2

1 reference

19 October 2017

Teresa Spanu

4

1 reference

19 October 2017

Federica Antonicelli

5

1 reference

19 October 2017

Riccardo Maviglia

6

1 reference

19 October 2017

Giuseppe Bello

8

1 reference

19 October 2017

1 February 2013

1 reference

19 October 2017

Intensive Care Medicine

1 reference

19 October 2017

39

1 reference

19 October 2017

4

1 reference

19 October 2017

682-692

1 reference

https://scigraph.springernature.com/pub.10.1007/s00134-013-2828-9

19 October 2017

0 references

cites work

Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Defining, treating and preventing hospital acquired pneumonia: European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Pseudomonas aeruginosa: resistance and therapeutic options at the turn of the new millennium.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

In vivo development of antimicrobial resistance in Pseudomonas aeruginosa strains isolated from the lower respiratory tract of Intensive Care Unit patients with nosocomial pneumonia and receiving antipseudomonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Pneumonia due to Pseudomonas aeruginosa: part II: antimicrobial resistance, pharmacodynamic concepts, and antibiotic therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Multidrug-resistant Pseudomonas aeruginosa bloodstream infections: risk factors and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Optimal management therapy for Pseudomonas aeruginosa ventilator-associated pneumonia: An observational, multicenter study comparing monotherapy with combination antibiotic therapy*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Nosocomial pneumonia in ventilated patients: a cohort study evaluating attributable mortality and hospital stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Candida colonization of the respiratory tract and subsequent pseudomonas ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Multidrug-resistant Pseudomonas aeruginosa ventilator-associated pneumonia: the role of endotracheal aspirate surveillance cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Impact of ureido/carboxypenicillin resistance on the prognosis of ventilator-associated pneumonia due to Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Impact of piperacillin resistance on the outcome of Pseudomonas ventilator-associated pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Pseudomonas aeruginosa ventilator-associated pneumonia: comparison of episodes due to piperacillin-resistant versus piperacillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Persistent infection with Pseudomonas aeruginosa in ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Identifying new risk factors for Pseudomonas aeruginosa pneumonia in intensive care units: experience of the French national surveillance, REA-RAISIN.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Risk Factors for Ventilator-associated Pneumonia by Pseudomonas aeruginosa in Presence of Recent Antibiotic Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic "blind" bronchoalveolar lavage fluid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Serial evaluation of the SOFA score to predict outcome in critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Pneumonia due to Pseudomonas aeruginosa: part I: epidemiology, clinical diagnosis, and source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Risk factors for antimicrobial resistance and influence of resistance on mortality in patients with bloodstream infection caused by Pseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Impact of inappropriate antibiotic therapy on mortality in patients with ventilator-associated pneumonia and blood stream infection: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Microbial resistance: lessons from the EPIC study. European Prevalence of Infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Global spread of Carbapenemase-producing Enterobacteriaceae

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Clinical and economic impact of common multidrug-resistant gram-negative bacilli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Costs of bloodstream infections caused by Escherichia coli and influence of extended-spectrum-beta-lactamase production and inadequate initial antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Attributable hospital cost and length of stay associated with health care-associated infections caused by antibiotic-resistant gram-negative bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Methicillin-resistant Staphylococcus aureus prolongs intensive care unit stay in ventilator-associated pneumonia, despite initially appropriate antibiotic therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Inappropriate antibiotic therapy in Gram-negative sepsis increases hospital length of stay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00134-013-2828-9

Ventilator-associated pneumonia caused by multidrug-resistant organisms or Pseudomonas aeruginosa: prevalence, incidence, risk factors, and outcomes

21 January 2018

1 reference

12 December 2020

Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia

1 reference

12 December 2020

A new Simplified Acute Physiology Score (SAPS II) based on a European/North American multicenter study

1 reference

12 December 2020

Severity of ICU-acquired pneumonia according to infectious microorganisms

1 reference

12 December 2020

Superinfections in Pseudomonas aeruginosa ventilator-associated pneumonia

1 reference

12 December 2020

10.1007/S00134-013-2828-9

Identifiers

DOI

1 reference

19 October 2017

1 reference